Therapeutic effects of intra-arterial administration of glial progenitor cells-conditioned medium in acute experimental ishemic stroke in rats


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Transplantation of various types of stem cells as a possible therapy for stroke has been tested for years and the results are promising. Recently, most researchers are inclined to assume that the therapeutic effect of stem cell therapy is based on the mechanism of paracrine action associated with the secretion wide set of regulatory proteins. The aim of this study was to evaluate therapeutic effects of iPSC-derived glial progenitor cells conditioned medium in the rat middle cerebral artery occlusion model of the ischemic stroke. We showed that intra-arterial administration of glial progenitor cells conditioned medium promoted faster decrease of neurological deficit compared to the control group. Moreover, expression of gap43, bax, and tnfa genes involved in neuritogenesis, apoptosis and neuroinflammation was altered. However, no significant enhanced reduction of the infarct volume was registered. Our results demonstrated that administration of glial progenitor cells conditioned medium induced functional recovery after experimental stroke and may affect brain plasticity.

Full Text

Restricted Access

About the authors

E. A Cherkashova

Federal Center for brain and neurotechnology of the Federal medical and biological agency

D. I Salikhova

Research Centre for Medical Genetics; Research Institute of Human Morphology

D. D Namestnikova

N.I. Pirogov Russian National Research Medical University

G. E Leonov

Research Centre for Medical Genetics

I. L Gubskiy

Federal Center for brain and neurotechnology of the Federal medical and biological agency

A. A Solovieva

Federal Center for brain and neurotechnology of the Federal medical and biological agency

G. B Akopyan

Federal Center for brain and neurotechnology of the Federal medical and biological agency

V. V Kurilo

N.I. Pirogov Russian National Research Medical University

M. P Nikitina

Research Institute of Human Morphology

T. Kh Fatkhudinov

Research Institute of Human Morphology; Peoples' Friendship University of Russia

V. P Chekhonin

N.I. Pirogov Russian National Research Medical University

L. V Gubskiy

Federal Center for brain and neurotechnology of the Federal medical and biological agency; N.I. Pirogov Russian National Research Medical University

K. N Yarygin

V.N. Orehovich Institute of Biomedical Chemistry; Russian Medical Academy of Continuous Professional Education

T. B Bukharova

Research Centre for Medical Genetics

D. V Goldshtein

Research Centre for Medical Genetics; Peoples' Friendship University of Russia

References

  1. Powers W.J., Rabinstein A.A., Ackerson T. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50(12): 344-8.
  2. Donkor E.S. Stroke in the Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke research and treatment 2018; 2018: 1-10.
  3. Marei H.E., Hasan A., Rizzi R. et al. Potential of Stem Cell-Based Therapy for Ischemic Stroke. Front. Neurol. 2018; 9: 34.
  4. Xu W., Zheng J., Gao L. et al. Neuroprotective Effects of Stem Cells in Ischemic Stroke. Stem cells international 2017; 2017: 1-7.
  5. Abeliovich A., Doege C.A. Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease. Neuron 2009; 61(3): 337-9.
  6. Okano H., Yamanaka S. iPS cell technologies: significance and applications to CNS regeneration and disease. Molecular brain 2014; 7(1): 22-5
  7. Poulos J. The limited application of stem cells in medicine: a review. Stem cell research & therapy 2018; 9(1): 1-6.
  8. Jha M.K., Seo M., Kim J.H. et al. The secretome signature of reactive glial cells and its pathological implications. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 2013; 1834(11): 2418-28.
  9. Ruiz C., Casarejos M.J., Gomez A. et al. Protection by glia-conditioned medium in a cell model of Huntington disease. PLoS Сurrents 2012; 4: 20-8.
  10. Салихова Д.И., Леонов Г.Е., Бухарова Т.Б. и др. Сравнительный анализ влияния кондиционированных сред, полученных от нейрональных и глиальных предшественников, на мозжечковые нейроны при глутаматной эксайтотоксичности. Гены и Клетки 2019; 14(4): 46-53.
  11. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
  12. Koizumi J. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Japanese Journal of Stroke 1986; 8: 1-8.
  13. Longa E.Z., Weinstein P.R., Carlson S. et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20(1): 84-91.
  14. Gubskiy I.L., Namestnikova D.D., Cherkashova E.A. et al. MRI Guiding of the middle cerebral artery occlusion in rats aimed to improve stroke modeling. Translational stroke research 2018; 9(4): 417-25.
  15. Schaar K.L., Brenneman M.M., Savitz S.I. et al. Functional assessments in the rodent stroke model. Experimental & translational stroke medicine 2010; 2(1): 13.
  16. Tuttolomondo A., Raimondo D., Sciacca R. et al. Inflammatory cytokines in acute ischemic stroke. Current pharmaceutical design 2008; 14(33): 3574-89.
  17. Janssen K., Bahnassawy L., Kiefer C. et al. Generating human iPSC-derived astrocytes with chemically defined medium for in vitro disease modeling. Methods Mol. Biol. 2019; 1994: 31-9.
  18. Yang H., Wang C., Chen H. et al. Neural stem cell-conditioned medium ameliorated cerebral ischemia-reperfusion injury in rats. Stem cells international 2018; 2018: 1-7.
  19. Tsai M.J., Tsai S.K., Hu B.R. et al. Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. Journal of biomedical science 2014; 21(1): 1-12.
  20. Watanabe T., Nagai A., Sheikh A.M. et al. Human neural stem cell line provides neuroprotection and improves neurological performance by early intervention of neuroinflammatory system. Brain research 2016; 1631: 194-203.

Copyright (c) 2020 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 85657 от 21.07.2023 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies